Where should I publish my paper?
Paste your title, abstract or keywords. The finder matches them to research topics and suggests ranked journals that publish most on those topics.
Journals for “Biosimilars and Bioanalytical Methods”
Suggested journals
Topic match is relative to the best match in this search (100% = best). Under each journal, "Publishes on" shows which of the matched topics it publishes and what share of its recent papers they make up. Fees are shown only where DOAJ records them; "Not recorded" does not mean the journal is free.
| # | Journal | Topic match | ITS Journal Score | Global rank | Papers 2021–2025 | Open access | Fee (APC) | Compare |
|---|---|---|---|---|---|---|---|---|
| 1 | Bioanalysis Future Science Ltd · United Kingdom Publishes on: Biosimilars and Bioanalytical Methods (29%) | 98% | 72.6 | #5,343 | 696 | 48% | Not recorded | |
| 2 | Generics and Biosimilars Initiative Journal Belgium Publishes on: Biosimilars and Bioanalytical Methods (29%) | 100% | 48.6 | #20,596 | 128 | 4% | Not recorded | |
| 3 | BioDrugs Adis, Springer Healthcare · Switzerland Publishes on: Biosimilars and Bioanalytical Methods (21%) | 71% | 79.9 | #2,203 | 296 | 65% | Not recorded | |
| 4 | The AAPS Journal Springer Science+Business Media · United States Publishes on: Biosimilars and Bioanalytical Methods (16%) | 54% | 77.9 | #2,914 | 647 | 52% | Not recorded | |
| 5 | Journal of Applied Bioanalysis Betasciencepress Publishers · The Netherlands Publishes on: Biosimilars and Bioanalytical Methods (18%) | 63% | 38.2 | #30,347 | 2,462 | 100% | Not recorded | |
| 6 | Drugs in R&D Adis, Springer Healthcare · New Zealand · DOAJ Publishes on: Biosimilars and Bioanalytical Methods (10%) | 34% | 68.4 | #7,736 | 195 | 100% | 2,690 EUR | |
| 7 | Biologics Multidisciplinary Digital Publishing Institute · Switzerland · DOAJ Publishes on: Biosimilars and Bioanalytical Methods (11%) | 38% | 56.9 | #14,876 | 132 | 100% | 1,000 CHF | |
| 8 | Biologics Dove Medical Press · New Zealand · DOAJ Publishes on: Biosimilars and Bioanalytical Methods (9%) | 30% | 69.3 | #7,223 | 166 | 100% | US$4,320 | |
| 9 | The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products Regulatory Research and Medicine Evaluation NEICON ISP LLC · Russia · DOAJ Publishes on: Biosimilars and Bioanalytical Methods (11%) | 37% | 50.4 | #19,201 | 146 | 100% | Not recorded | |
| 10 | Therapeutic Drug Monitoring Lippincott Williams & Wilkins · United States Publishes on: Biosimilars and Bioanalytical Methods (7%) | 25% | 71.5 | #5,974 | 559 | 36% | Not recorded | |
| 11 | Journal of Mass Spectrometry and Advances in the Clinical Lab Elsevier BV · The Netherlands Publishes on: Biosimilars and Bioanalytical Methods (8%) | 28% | 63.7 | #10,561 | 186 | 100% | Not recorded | |
| 12 | Biomedical Chromatography Wiley · United Kingdom Publishes on: Biosimilars and Bioanalytical Methods (7%) | 22% | 70.4 | #6,535 | 1,433 | 27% | Not recorded | |
| 13 | The Journal of Applied Laboratory Medicine Oxford University Press · United States Publishes on: Biosimilars and Bioanalytical Methods (7%) | 23% | 66.1 | #9,123 | 843 | 52% | Not recorded | |
| 14 | Biochemia Medica Croatian society of medical biochemistry and laboratory medicine · Croatia · DOAJ Publishes on: Biosimilars and Bioanalytical Methods (6%) | 19% | 71.6 | #5,879 | 233 | 100% | Not recorded | |
| 15 | PDA Journal of Pharmaceutical Science and Technology Parenteral Drug Association · United States Publishes on: Biosimilars and Bioanalytical Methods (9%) | 31% | 48.6 | #20,546 | 274 | 5% | Not recorded | |
| 16 | Biologicals Elsevier BV · United Kingdom Publishes on: Biosimilars and Bioanalytical Methods (6%) | 19% | 70.0 | #6,789 | 228 | 45% | Not recorded | |
| 17 | Pharmaceutical Patent Analyst Future Science Ltd · United Kingdom Publishes on: Biosimilars and Bioanalytical Methods (7%) | 26% | 57.2 | #14,655 | 107 | 29% | Not recorded | |
| 18 | AAPS Open Springer Nature · Germany · DOAJ Publishes on: Biosimilars and Bioanalytical Methods (8%) | 27% | 53.1 | #17,323 | 99 | 100% | 1,690 EUR | |
| 19 | Crohn s & Colitis 360 Oxford University Press · United States · DOAJ Publishes on: Biosimilars and Bioanalytical Methods (6%) | 22% | 62.4 | #11,359 | 345 | 100% | US$3,217 | |
| 20 | Drug Metabolism and Bioanalysis Letters Bentham Science Publishers Publishes on: Biosimilars and Bioanalytical Methods (10%) | 33% | 42.4 | #25,903 | 69 | 6% | Not recorded | |
| 21 | Journal of Crohn s and Colitis Oxford University Press · United Kingdom Publishes on: Biosimilars and Bioanalytical Methods (5%) | 17% | 72.2 | #5,615 | 6,852 | 69% | Not recorded | |
| 22 | Expert Opinion on Investigational Drugs Taylor & Francis · United Kingdom Publishes on: Biosimilars and Bioanalytical Methods (3%) | 9% | 78.8 | #2,567 | 501 | 30% | Not recorded | |
| 23 | Clinical Drug Investigation Adis, Springer Healthcare · New Zealand Publishes on: Biosimilars and Bioanalytical Methods (3%) | 11% | 71.9 | #5,733 | 509 | 55% | Not recorded | |
| 24 | Advances in Laboratory Medicine / Avances en Medicina de Laboratorio De Gruyter · Germany · DOAJ Publishes on: Biosimilars and Bioanalytical Methods (7%) | 23% | 48.9 | #20,316 | 369 | 100% | Not recorded | |
| 25 | Global & Regional Health Technology Assessment SAGE Publishing · Italy · DOAJ Publishes on: Biosimilars and Bioanalytical Methods (7%) | 25% | 45.3 | #23,229 | 145 | 100% | 1,500 EUR | |
| 26 | Acta Pharmaceutica Hungarica Hungarian Society for Pharmaceutical Sciences · Hungary Publishes on: Biosimilars and Bioanalytical Methods (9%) | 29% | 36.1 | #32,669 | 142 | 100% | Not recorded | |
| 27 | Biopharma Dealmakers Springer Nature · United Kingdom Publishes on: Biosimilars and Bioanalytical Methods (7%) | 26% | 37.2 | #31,437 | 90 | 70% | Not recorded | |
| 28 | Latin American Journal of Clinical Sciences and Medical Technology Mexico Publishes on: Biosimilars and Bioanalytical Methods (8%) | 27% | 19.6 | #53,095 | 118 | 100% | Not recorded |
Before you submit
Use this list as a shortlist, not a decision. For each journal, read its aims and scope and a few recent articles, check its peer-review and fee policy on its own website, and confirm any indexing (Scopus, Web of Science, PubMed) with the indexer itself. Be careful with journals that promise very fast acceptance or that contact you by email asking for papers.
How the ITS Journal Score works
One formula applies to every ranked journal, using open data from OpenAlex: 45% citation impact, 35% h-index and 20% size (papers published 2021–2025). Citation impact is the smaller of the journal's two-year mean citedness and its five-year citations per paper, so a journal whose output collapsed cannot jump to the top on old citations. Each part is half a percentile and half a log-scaled value, so the very top is still separated. Growth and open-access share are shown separately and are not part of the score.
A journal is ranked only if it published at least 50 papers in 2021–2025 and was active in at least five of the last six years. Field rankings compare a journal only with journals in the same field; the field is the OpenAlex field with most of the journal's recent papers, or "Multidisciplinary" when no field has 30% of them.
What this is not: the ITS Journal Score is not a Journal Impact Factor, CiteScore or SJR, and this site does not say whether a journal is indexed in Scopus, Web of Science or PubMed. Always confirm aims and scope, indexing, peer review and fees on the journal's own website before you submit.